This is a Validated Antibody Database (VAD) review about human ARID1A, based on 32 published articles (read how Labome selects the articles), using ARID1A antibody in all methods. It is aimed to help Labome visitors find the most suited ARID1A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ARID1A synonym: B120; BAF250; BAF250a; BM029; C1orf4; CSS2; ELD; MRD14; OSA1; P270; SMARCF1; hELD; hOSA1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (PSG3)
  • western blot knockout validation; human; 1:1000; loading ...; fig e4e
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761) was used in western blot knockout validation on human samples at 1:1000 (fig e4e). Nat Cancer (2022) ncbi
Abcam
domestic rabbit monoclonal (EPR13501)
  • immunohistochemistry knockout validation; mouse; 1:1000; loading ...; fig 1e
  • western blot knockout validation; mouse; 1:2000; loading ...; fig s5-2e
Abcam ARID1A antibody (Abcam, 182560) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig 1e) and in western blot knockout validation on mouse samples at 1:2000 (fig s5-2e). elife (2020) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:500; loading ...; fig s2a
  • western blot; mouse; 1:500; loading ...; fig 6f
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:500 (fig s2a) and in western blot on mouse samples at 1:500 (fig 6f). Nat Commun (2022) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1c, e1b, e2h
  • immunohistochemistry; human; 1:1000; fig 5f
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:1000 (fig 1c, e1b, e2h) and in immunohistochemistry on human samples at 1:1000 (fig 5f). Nat Cancer (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1b
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:1000 (fig 1b). Sci Adv (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:1000; loading ...; fig s1
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:1000 (fig s1). Mol Cell Proteomics (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (PSG3)
  • western blot knockout validation; human; 1:1000; loading ...; fig e4e
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761) was used in western blot knockout validation on human samples at 1:1000 (fig e4e). Nat Cancer (2022) ncbi
mouse monoclonal (C-7)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz Biotechnology, sc-373784) was used in western blot on human samples (fig 3b). Nature (2019) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1
Santa Cruz Biotechnology ARID1A antibody (Santa-Cruz, sc-32761) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). BMC Cancer (2019) ncbi
mouse monoclonal (PSG3)
  • immunoprecipitation; human; loading ...; fig 2b
  • western blot; mouse; loading ...; fig 1d
Santa Cruz Biotechnology ARID1A antibody (SantaCruz, sc-32761) was used in immunoprecipitation on human samples (fig 2b) and in western blot on mouse samples (fig 1d). J Biol Chem (2018) ncbi
mouse monoclonal (PSG3)
  • western blot; human; 1:1000; loading ...; fig 1-s1a
Santa Cruz Biotechnology ARID1A antibody (SantaCruz, sc-32761) was used in western blot on human samples at 1:1000 (fig 1-s1a). elife (2017) ncbi
mouse monoclonal (PSG3)
  • western blot; human; 1:1000; loading ...; fig 3f
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz Biotechnology Inc, sc-32761) was used in western blot on human samples at 1:1000 (fig 3f). Nat Cell Biol (2017) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, SC-32761) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). Biomed Res Int (2016) ncbi
mouse monoclonal (PSG3)
  • RNA immunoprecipitation; mouse; fig s5
  • western blot; mouse
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761) was used in RNA immunoprecipitation on mouse samples (fig s5) and in western blot on mouse samples . Nat Struct Mol Biol (2016) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 2c
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz Biotechnology, sc-32761) was used in immunohistochemistry on mouse samples at 1:50 (fig 2c). Dev Biol (2016) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 1
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, SC-32761) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1). J Breast Cancer (2015) ncbi
mouse monoclonal (PSG3)
  • immunoprecipitation; human; fig 3
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761x) was used in immunoprecipitation on human samples (fig 3). PLoS Genet (2015) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry - frozen section; human; 1:150; fig 3
  • western blot; human; 1:500; fig s22
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, SC-32761) was used in immunohistochemistry - frozen section on human samples at 1:150 (fig 3) and in western blot on human samples at 1:500 (fig s22). Nat Commun (2015) ncbi
mouse monoclonal (C-7)
  • immunoprecipitation; human; fig 2
In order to elucidate how microphthalmia-associated transcription factor regulates transcription, Santa Cruz Biotechnology ARID1A antibody (Santa Cruz Biotechnology, sc-373784) was used in immunoprecipitation on human samples (fig 2). elife (2015) ncbi
mouse monoclonal (PSG3)
  • immunoprecipitation; human; 1:10; fig s9
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, PSG3) was used in immunoprecipitation on human samples at 1:10 (fig s9). Nature (2015) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry - paraffin section; mouse; 1:50
Santa Cruz Biotechnology ARID1A antibody (Santa, sc-32761) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. Nat Commun (2015) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry; human; 1:300; fig 2, 3
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761) was used in immunohistochemistry on human samples at 1:300 (fig 2, 3). Cell Rep (2014) ncbi
mouse monoclonal (PSG3)
  • immunohistochemistry - paraffin section; mouse
  • chromatin immunoprecipitation; mouse
  • immunoprecipitation; mouse
  • western blot; mouse
Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761) was used in immunohistochemistry - paraffin section on mouse samples , in chromatin immunoprecipitation on mouse samples , in immunoprecipitation on mouse samples and in western blot on mouse samples . Nucleic Acids Res (2014) ncbi
mouse monoclonal (PSG3)
  • chromatin immunoprecipitation; mouse
  • immunoprecipitation; mouse
In order to investigate the role of ARID1a-DNA interactions in the SWI/SNF chromatin-remodeling complex, Santa Cruz Biotechnology ARID1A antibody (Santa Cruz, sc-32761) was used in chromatin immunoprecipitation on mouse samples and in immunoprecipitation on mouse samples . Mol Cell Biol (2013) ncbi
Abcam
domestic rabbit monoclonal (EPR13501)
  • other; human; 1:100; loading ...; fig 2d
Abcam ARID1A antibody (Abcam, ab182560) was used in other on human samples at 1:100 (fig 2d). Nat Cancer (2021) ncbi
domestic rabbit monoclonal (EPR13501)
  • immunohistochemistry knockout validation; mouse; 1:1000; loading ...; fig 1e
  • western blot knockout validation; mouse; 1:2000; loading ...; fig s5-2e
Abcam ARID1A antibody (Abcam, 182560) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig 1e) and in western blot knockout validation on mouse samples at 1:2000 (fig s5-2e). elife (2020) ncbi
domestic rabbit monoclonal (EPR13501)
  • ChIP-Seq; human; loading ...; fig 3a
Abcam ARID1A antibody (Abcam, ab182560) was used in ChIP-Seq on human samples (fig 3a). Sci Adv (2019) ncbi
domestic rabbit monoclonal (EPR13501)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1a, 1c, 1e
Abcam ARID1A antibody (Abcam, ab182560) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1a, 1c, 1e). Hum Pathol (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:500; loading ...; fig s2a
  • western blot; mouse; 1:500; loading ...; fig 6f
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:500 (fig s2a) and in western blot on mouse samples at 1:500 (fig 6f). Nat Commun (2022) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1c, e1b, e2h
  • immunohistochemistry; human; 1:1000; fig 5f
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:1000 (fig 1c, e1b, e2h) and in immunohistochemistry on human samples at 1:1000 (fig 5f). Nat Cancer (2021) ncbi
domestic rabbit monoclonal (D2A8U)
  • ChIP-Seq; mouse; 4-10 ug / antibody; loading ...; fig 1c
  • western blot; mouse; loading ...; fig 2i
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in ChIP-Seq on mouse samples at 4-10 ug / antibody (fig 1c) and in western blot on mouse samples (fig 2i). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot; human; loading ...; fig 4a
  • immunohistochemistry; mouse; loading ...; fig 4d
Cell Signaling Technology ARID1A antibody (Cell Signaling Technology, 12354) was used in western blot on human samples (fig 4a) and in immunohistochemistry on mouse samples (fig 4d). Cell Rep (2020) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology ARID1A antibody (Cell Signaling Technology, D2A8U) was used in western blot on human samples at 1:1000. J Virol (2020) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot; human; 1:1000; loading ...; fig s4r
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot on human samples at 1:1000 (fig s4r). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1b
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:1000 (fig 1b). Sci Adv (2019) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot; human; 1:1000; loading ...; fig 4a,4b
Cell Signaling Technology ARID1A antibody (Cell Signalling Technology, 12354) was used in western blot on human samples at 1:1000 (fig 4a,4b). Am J Cancer Res (2017) ncbi
domestic rabbit monoclonal (D2A8U)
  • chromatin immunoprecipitation; human; 1:1000; loading ...; fig s4d
  • immunoprecipitation; human; loading ...; fig 3g
  • western blot; human; 1:1000
In order to study lncBRM and YAP1 signaling in liver cancer stem cells and hepatocellular carcinoma, Cell Signaling Technology ARID1A antibody (Cell signalling, 12354) was used in chromatin immunoprecipitation on human samples at 1:1000 (fig s4d), in immunoprecipitation on human samples (fig 3g) and in western blot on human samples at 1:1000. Nat Commun (2016) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot; human; loading ...; fig 6a
In order to report the O-linked N-acetylglucosamine glycoproteome observed in human T cells, Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot on human samples (fig 6a). J Immunol (2016) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot knockout validation; human; 1:1000; loading ...; fig s1
Cell Signaling Technology ARID1A antibody (Cell Signaling, 12354) was used in western blot knockout validation on human samples at 1:1000 (fig s1). Mol Cell Proteomics (2016) ncbi
domestic rabbit monoclonal (D2A8U)
  • western blot; human; 1:500; loading ...; fig 5b
Cell Signaling Technology ARID1A antibody (Cell signaling, 12354) was used in western blot on human samples at 1:500 (fig 5b). Oncotarget (2016) ncbi
Articles Reviewed
  1. Liu X, Viswanadhapalli S, Kumar S, Lee T, Moore A, Ma S, et al. Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress. Nat Cancer. 2022;: pubmed publisher
  2. Wedge M, Jennings V, Crupi M, Poutou J, Jamieson T, Pelin A, et al. Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy. Nat Commun. 2022;13:1898 pubmed publisher
  3. Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021;2:189-200 pubmed publisher
  4. Park Y, Lee J, Yan Z, McKernan K, O Haren T, Wang W, et al. Interplay of BAF and MLL4 promotes cell type-specific enhancer activation. Nat Commun. 2021;12:1630 pubmed publisher
  5. Wilson M, Reske J, Holladay J, Neupane S, Ngo J, Cuthrell N, et al. ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation. Cell Rep. 2020;33:108366 pubmed publisher
  6. Riou R, Ladli M, Gerbal Chaloin S, Bossard P, Gougelet A, Godard C, et al. ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription. elife. 2020;9: pubmed publisher
  7. Asha K, Balfe N, Sharma Walia N. Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4. J Virol. 2020;94: pubmed publisher
  8. Ballabio C, Anderle M, Gianesello M, Lago C, Miele E, Cardano M, et al. Modeling medulloblastoma in vivo and with human cerebellar organoids. Nat Commun. 2020;11:583 pubmed publisher
  9. Inoue D, Chew G, Liu B, Michel B, Pangallo J, D Avino A, et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature. 2019;574:432-436 pubmed publisher
  10. Wu S, Fatkhutdinov N, Rosin L, Luppino J, Iwasaki O, Tanizawa H, et al. ARID1A spatially partitions interphase chromosomes. Sci Adv. 2019;5:eaaw5294 pubmed publisher
  11. Bi C, Liu M, Rong W, Wu F, Zhang Y, Lin S, et al. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study. BMC Cancer. 2019;19:213 pubmed publisher
  12. Barreta A, Sarian L, Ferracini A, Costa L, Mazzola P, de Angelo Andrade L, et al. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. Hum Pathol. 2019;85:72-81 pubmed publisher
  13. Alpsoy A, Dykhuizen E. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. J Biol Chem. 2018;293:3892-3903 pubmed publisher
  14. Kelso T, Porter D, Amaral M, Shokhirev M, Benner C, Hargreaves D. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. elife. 2017;6: pubmed publisher
  15. Bitler B, Wu S, Park P, Hai Y, Aird K, Wang Y, et al. ARID1A-mutated ovarian cancers depend on HDAC6 activity. Nat Cell Biol. 2017;19:962-973 pubmed publisher
  16. Nastase A, Teo J, Heng H, Ng C, Myint S, Rajasegaran V, et al. Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors. Am J Cancer Res. 2017;7:484-502 pubmed
  17. Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B, et al. LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat Commun. 2016;7:13608 pubmed publisher
  18. Lund P, Elias J, Davis M. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells. J Immunol. 2016;197:3086-3098 pubmed
  19. Goldman A, Bitler B, Schug Z, Conejo Garcia J, Zhang R, Speicher D. The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level. Mol Cell Proteomics. 2016;15:3348-3360 pubmed
  20. Nettersheim D, Jostes S, Fabry M, Honecker F, Schumacher V, Kirfel J, et al. A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. Oncotarget. 2016;7:74931-74946 pubmed publisher
  21. Wu Y, Gu Y, Guo S, Dai Q, Zhang W. Expressing Status and Correlation of ARID1A and Histone H2B on Breast Cancer. Biomed Res Int. 2016;2016:7593787 pubmed publisher
  22. Flynn R, Do B, Rubin A, Calo E, Lee B, Kuchelmeister H, et al. 7SK-BAF axis controls pervasive transcription at enhancers. Nat Struct Mol Biol. 2016;23:231-8 pubmed publisher
  23. Chandler R, Magnuson T. The SWI/SNF BAF-A complex is essential for neural crest development. Dev Biol. 2016;411:15-24 pubmed publisher
  24. Cho H, Lee J, Jung H, Oh M, Lee J, Jang S, et al. Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer. J Breast Cancer. 2015;18:339-46 pubmed publisher
  25. Raab J, Resnick S, Magnuson T. Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. PLoS Genet. 2015;11:e1005748 pubmed publisher
  26. Witkiewicz A, McMillan E, Balaji U, Baek G, Lin W, Mansour J, et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015;6:6744 pubmed publisher
  27. Laurette P, Strub T, Koludrovic D, Keime C, Le Gras S, Seberg H, et al. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells. elife. 2015;4: pubmed publisher
  28. Fillmore C, Xu C, Desai P, Berry J, Rowbotham S, Lin Y, et al. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature. 2015;520:239-42 pubmed publisher
  29. Chandler R, Damrauer J, Raab J, Schisler J, Wilkerson M, Didion J, et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 2015;6:6118 pubmed publisher
  30. Nordentoft I, Lamy P, Birkenkamp Demtroder K, Shumansky K, Vang S, Hornshøj H, et al. Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep. 2014;7:1649-1663 pubmed publisher
  31. Singh A, Archer T. Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation. Nucleic Acids Res. 2014;42:2958-75 pubmed publisher
  32. Chandler R, Brennan J, Schisler J, Serber D, Patterson C, Magnuson T. ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. Mol Cell Biol. 2013;33:265-80 pubmed publisher